FDA approves Eli Lilly’s GLP-1 pill, opening the next phase of the weight loss drug market
The US Food and Drug Administration has approved it Eli LillyPills GLP-1 ‘s, said the company, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight loss medications. Lilly said the once-daily pill, Foundayo, will begin shipping from LillyDirect’s direct-to-consumer platform on Monday and will be available in … Read more